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Abstract
Introduction
Preventive screening is widely recognized as a key com-
ponent of cost-effective, high-quality health care. Even so,
national screening for cancer, diabetes, and cholesterol
falls far short of U.S. Preventive Services Task Force rec-
ommendations. Although evidence has shown that
reminder programs improve preventive screening rates,
this study is one of the first to examine the characteristics
of health plan members who respond to screening
reminders.
Methods
The study sample included active members of a large
health plan in Hawaii who were identified by an algorithm
as not having received one or more recommended screen-
ings based on age and sex criteria (2000–2003) for breast
cancer (n = 44,331), cervical cancer (n = 73,875), colon can-
cer (n = 131,860), diabetes (n = 86,216), and cholesterol (n
= 54,843).
Statistical analyses were conducted using Cox propor-
tional hazard and logistic regression models. In the pro-
portional hazard models, reminder letters were treated as
time-varying exposures. Hazard ratios, or rate ratios,
were used to examine the relationship between health plan
member and physician characteristics and the likelihood of
responding to the reminders. The effects of additional or
multiple reminders among health plan members receiving
more than one reminder were examined in multivariable
regression models.
Results
The impact of health plan member characteristics and
number of office visits on the response to reminders varied
among the five health-screening types. Health plan mem-
bers responded better to reminders for diabetes screening
than for colon cancer screening. Members sent their second
annual reminders were less likely to obtain screening than
members sent their first reminder. Members receiving
their third (or more) annual reminder were especially
recalcitrant.
Conclusion
Our findings suggest that the response to reminders dif-
fers according to patient characteristics. In particular, tar-
geted interventions may be needed to encourage screening
for younger and healthier members whose response rate to
reminders was low. Further research is needed to deter-
mine how health plans can best reach members who do not
respond to patient reminders.
Introduction
Preventive screening is widely recognized as a key com-
ponent of cost-effective, high-quality health care. Even so,
national screening for cancer, diabetes, and cholesterol
falls far short of U.S. Preventive Services Task Force rec-
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ommendations (1). Prior evidence suggests that the likeli-
hood of receiving screening is associated with managed
care plan activity, including market penetration, type of
coverage, and use of gatekeepers (2-5).
In an effort to improve screening rates, many managed
care plans send patient and physician reminders for pre-
ventive care screening for health plan members who are
overdue for screenings based on national guidelines (6-11).
Although some studies have shown that these reminders
have no impact (12), several meta-analyses have indicated
that reminder programs for patients and physicians
improve preventive screening rates (13,14). Few studies,
however, have focused on understanding which type of
patient might benefit from these reminders.
A large health insurer in Hawaii has been providing its
members and physicians with screening reminders since
1997. The program aims to provide members with the best
opportunity for early detection and successful treatment of
breast, cervical, and colon cancer as well as to encourage
diabetes and cholesterol screenings. This study monitored
members who were overdue for recommended preventive
screenings. Members known to have obtained health
screenings were not included in the study.
This study sought to understand the relation of health
plan member characteristics, physician specialty, and pre-
vious health plan member use of medical services to the
response to screening reminders for breast cancer, cervical
cancer, colon cancer, diabetes, and cholesterol testing. The
study also examined the influence of multiple reminders
on health plan members overdue for more than one health
screening.
Methods
Study population
The eligible population included active members of a
health maintenance organization who were sent reminder
letters about overdue health screenings as indicated by the
recommendations of the U.S. Preventive Services Task
Force guidelines (1). The guidelines provide criteria based
on age, sex, and the frequency of screening. Active mem-
bers were health plan members who were enrolled with
the insurer. The health insurer maintained a registry of
health plan members to whom the health screening
reminders were mailed. This study used information avail-
able in the registry between January 1, 2000, and
December 31, 2003. The data used were administrative
data, the billing data from insurance claims. The age cri-
teria for screening were 41 to 90 years for breast cancer, 18
to 65 years for cervical cancer, 50 years and older for colon
cancer, 45 years and older for diabetes, 35 to 65 years for
males for cholesterol, and 45 to 65 years for women for cho-
lesterol. The total numbers of eligible members were
44,331 for breast cancer, 73,875 for cervical cancer,
131,860 (47% men and 53% women) for colon cancer,
86,216 (44% men and 56% women) for diabetes, and 54,843
(58% men and 42% women) for cholesterol. The members
consisted of approximately 52% fee for service (FFS), 40%
health maintenance organization (HMO), and 8%
Medicare plans. Reminder letters were sent every 2 years
for breast cancer, every 3 years for cervical cancer, every 5
years for diabetes and cholesterol, and every 1 or 5 years
for colon cancer, depending upon the types of previous
screening obtained. All active members were sent
reminders annually if they were known to have not
received the health screenings in accordance with the
guidelines. Members were considered overdue even if the
registry data were incomplete, as with members new to the
insurer, for example. At the beginning of the program,
reminders were mailed by the insurer on several dates
throughout the year. In 2002, the program began to send
birthday card reminders of overdue screenings on the 15th
of the members’ birth months. Members who were not
screened within 1 year were sent an additional reminder
on their next birthday. Personal care physicians also
received lists of members who had not been screened.
Table 1 shows the number of members sent screening
reminders by age and sex.
Health plan member demographics and medical history
The member characteristics examined included the
number of screening reminders received (i.e., one, two, or
three or more); sex; age classified into nine groups (20
years or younger, 21 to 30 years, 31 to 40 years, 41 to 50
years, 51 to 60 years, 61 to 70 years, 71 to 80 years, 81 to
90 years, and 91 years or older); morbidity level by
Adjusted Clinical Groups (ACGs) (12) (on a scale of 0 to 5,
measuring the level of illness experienced during the year
before the reminders were sent, with 5 representing the
greatest illness level); type of coverage (HMO, FFS, or
Medicare cost contract plan); the specialty of the primary
care physician (including general practice, family practice,
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obstetricians and gynecologists [OB/GYNs], and “other”
specialties); the number of office visits, emergency room
visits, and hospitalizations in the past year (classified as
no visit or one or more visits); and the calendar months
when the reminders were sent.
Statistical analysis
Statistical analyses were conducted using Cox propor-
tional hazard and logistic regression models. In this study,
additional reminders refer to more than one reminder for
the same type of screening (e.g., breast cancer screening
reminders sent in different years); multiple reminders
refer to the reminders sent for different types of screenings
(e.g., breast and colon cancer screening reminders).
Reminder letters (additional and multiple) were treated as
time-varying exposures in the proportional hazard models,
which were used to examine the relationship between
member and physician characteristics and the relative
response rates to the reminders. The analyses were con-
ducted on the member level by examining the date of a first
reminder for a screening type and the date a member
received the recommended screening or the date the mem-
ber’s enrollment ended. Members were included in the
study for as long as they retained coverage with the insur-
er, even if they changed health plans. The effects of receiv-
ing additional reminders on obtaining a specific health
screening in the following year were analyzed using logis-
tic regression. All regression models were adjusted for the
island of residence in Hawaii; the number of reminders
sent; sex; age group; ACGs; the type of coverage; provider
specialty; and the number of office visits, emergency room
visits, and hospitalizations.
Screening rates were calculated as the number of mem-
bers who received screening within the year after
reminders were sent divided by the number of members
who were sent reminders. All analyses were performed
using SAS, version 9.0 (SAS Institute Inc, Cary, NC).
Results
Of the five health screenings, screening rates were high-
est for diabetes and lowest for colon cancer (Table 2). The
rate of members obtaining the recommended screenings
invariably declined with increasing reminder numbers.
For example, the response rate for cervical cancer screen-
ing was 29.6% after one reminder and 13.0% after three
reminders. Screening percentages by sex were consistent-
ly higher among women than men but by no more than
6.0% (20.0% versus 16.5% for colon cancer, 29.5% versus
28.9% for diabetes, and 26.3% versus 20.5% for cholesterol
testing) (data not shown).
Screening rates for all five screenings varied by the
month the screening reminder was sent (Figure).
Screening rates were highest for all health screening
reminders sent in June and decreased toward the end of
the year. The drop in screening rates from June to
December was approximately 20.0% for breast cancer
screenings, colon cancer screenings, and diabetes screen-
ings; the drop in screening during those months was 29%
for cervical cancer and cholesterol screenings.
In multivariable regression models, rate ratios varied by
member characteristics (Table 3). For each of five screen-
ing categories, the rate ratios decreased significantly with
the number of annual reminders the members received. By
contrast, rate ratios varied less by sex; in general, the dif-
ference in ratios between men and women was much
smaller than the difference in the ratios between age
groups. The rate ratios by age groups were generally low
for the youngest ages eligible to obtain screening. The rate
ratios peaked between the youngest and oldest eligible
ages for cancer and diabetes screenings but consistently
increased with age for cholesterol screening. For diabetes
and cholesterol screening, rate ratios steadily increased
with morbidity levels from 0 to 5, whereas cancer rate
ratios were highest at morbidity levels of 3 or 4. HMO
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Figure. Percentage of members responding to screening reminders by cal-
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members had the highest relative rates of breast and cer-
vical cancer screening; Medicare members had the highest
relative rates of colon cancer, diabetes, and cholesterol
screenings. FFS members consistently had the lowest
screening ratios among the three types of coverage.
Table 4 displays the rate ratios by the number of office
visits per year, the number of emergency room visits per
year, the number of hospitalizations per year, and provider
specialties. These data are derived from the year before the
members received overdue screening reminders. For
breast and cervical cancer screenings, rate ratios varied lit-
tle with increasing numbers of office visits. For colon can-
cer, rate ratios increased by 19.0% from 1 to 26 or more
office visits. For cholesterol screening, rate ratios for the
same comparison increased by 34% but were not statisti-
cally significant. Diabetes screening exhibited the
strongest trend with office visits; rate ratios increased by
66.0% from 1 to 26 or more office visits. Among the five
provider specialties, OB/GYNs had the highest relative
screening rates for the three cancer screenings. Only see-
ing a primary care physician was significantly associated
with diabetes screening. Seeing a primary care physician,
an endocrinologist, or a cardiologist was significantly asso-
ciated with obtaining cholesterol screening. Rate ratios
among members having an emergency room visit in the
past year generally decreased but at most by 11%. Among
members having a hospitalization in the past year, only
the rate ratio for breast, colon, and cholesterol screenings
decreased significantly.
Members who were sent reminders for multiple overdue
screenings were less likely to obtain the recommended
screenings than members who were reminded of only one
type of overdue screening (Table 5). Members who received
reminders for both breast and cervical cancer screenings,
for example, had less than half of the screening rates for
either cancer compared with members who received a
reminder for just one. There were also strong negative
associations between receiving a reminder for diabetes
screening and also receiving a reminder for cholesterol
screening. Members who were sent overdue screening
reminders for both screenings were one fourth as likely to
obtain the recommended screenings as members sent
reminders for only one of the two screenings.
Members who responded to reminders for one type of
screening were more likely to obtain other recommended
screenings (Table 6). For example, women who were sent
reminders for both cervical or breast cancer screenings —
and who obtained one of the recommended screenings —
were 8 to 10 times as likely to obtain the other cancer
screening. Weaker associations were apparent among
screening rates for colon, breast, and cervical cancers.
Diabetes and cholesterol screenings were strongly associ-
ated with each other; screening rates were 20 to 24 times
greater among members obtaining one of these health
screenings if a screening was obtained for the other.
Discussion
The impact of patient characteristics and prior use of
medical services on the response to reminders varied
among the five health-screening types, suggesting that atti-
tudes toward the different types of reminders may differ
among health plan members. For example, members
responded better to diabetes screening reminders than to
colon cancer screening reminders. Members who were sent
their second annual reminders were less likely to obtain
screening, and those who received their third (or more)
reminder were especially recalcitrant. Members who ignore
up to three reminders may require other approaches to suc-
cessfully encourage screening such as phone calls or addi-
tional reminders through their personal care physicians.
Although evidence has shown that reminder programs
increase preventive screening rates, this study is one of the
first to examine the characteristics of health plan members
who responded to screening reminders. Age was one of the
most consistent factors associated with responding to the
reminders. A previous study found that older patients and
patients with chronic conditions were less likely to respond
to screenings (15). The findings on age are consistent with
our results, except that we found older health plan mem-
bers responded better to cholesterol reminders than
younger health plan members. Although women had
slightly higher screening rates than men, the rate ratios
indicate little difference in the likelihood of response to the
screening reminders between men and women.
Morbidity was associated with screening based on an
index ranging from ACG level 0, which was considered to
be the “healthiest” group, to 5, which was considered to
be the most “seriously” ill (12). For the three cancer
screenings, the highest screening rates were found at the
morbidity levels of 3 and 4, indicating that moderately ill
members were more likely to respond to the cancer
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bers. Perhaps the healthier members tended to ignore
the cancer screening reminders, whereas the sickest
members may have addressed their more immediate ill-
nesses rather than their cancer screenings. With dia-
betes and cholesterol screening, however, screening
rates increased directly with morbidity levels. Sicker
members (or their physicians) may be more aware of the
required health screenings among members repeatedly
obtaining health care.
Members more often responded to the screening
reminders sent in June or earlier months than to the
reminders sent near the end of the year. Low end-of-the-
year response rates may be attributable to the year-end
holiday season, a season during which people may put off
or ignore the recommended screenings. This result may be
of practical importance. For some health plan members,
reminders sent in addition to their regular birthday
reminders may be beneficial in the summer, when mem-
bers may be more willing to obtain health screenings. 
Members of HMOs and the Medicare plan were more
likely to respond to screening reminders than FFS mem-
bers. One of the major differences between HMOs and
Medicare plans compared with FFS plans is that FFS
plans do not require a primary care physician. Having a
primary care physician may increase screening rates
among the HMO and Medicare members. Another expla-
nation could be the difference in coverage for preventive
services. FFS members have about 80% of their costs cov-
ered by their insurance, whereas HMO and Medicare
members (for most screenings) have 100% of their costs
covered. The higher member copayment among FFS
members may make some members less willing to seek
the recommended screenings. In this study, only diabetes
screening was significantly affected by the number of
health services and especially by the number of office vis-
its, whereas emergency room visits and hospitalization
had very little effect on screening rates. The type of
physician visited did appear to have selected effects on
receiving the recommended screenings. Women who vis-
ited an OB/GYN had improved screening rates for breast,
cervical, and colon cancer. By contrast, seeing a primary
care physician was weakly associated with improved
screening rates for diabetes, and seeing an endocrinolo-
gist or a cardiologist was associated with improved cho-
lesterol screening rates.
Members who received reminders for multiple overdue
health screenings had reduced screening rates. In particu-
lar, women who received a reminder for breast cancer
screening and a reminder for cervical cancer screening
were much less likely to obtain cervical cancer screening
and vice versa. Similarly, members who received a
reminder for both diabetes and cholesterol screening had
low screening rates for these two health screenings. On the
other hand, members who obtained one recommended
screening were more likely to obtain others. Women who
obtained cervical or breast cancer screening were nearly
four times as likely to obtain screening for the other.
Similarly, members who obtained a cholesterol or diabetes
screening were 14 to 17 times as likely to obtain the other.
The strong positive relation between breast and cervical
cancer screenings may be because these two cancer screen-
ings are mainly provided by OB/GYNs. The strong positive
associations between the diabetes and cholesterol screen-
ings may be attributable to the fact that both screening
services are often provided by PCPs. Efforts to improve
screening rates might benefit from targeting breast and
cervical cancer or cholesterol and diabetes screening as
pairs of related screenings.
In this study, several limitations should be considered
in interpreting the data. First, the population in this
study only consists of the members enrolled with one
insurer in Hawaii. The results and conclusions may not
generalize to other populations. Second, the analyses are
entirely based on administrative data. Any services ren-
dered outside the insurer’s system were not recorded.
Third, as a practical matter for this study, members were
sent reminders if they were considered overdue for recom-
mended screenings. However, some of the members who
were considered overdue may have already received the
recommended screenings before they enrolled with the
insurer. Fourth, family history, household income, and
ethnicity were not factored into our statistical models.
This information was not available but may have influ-
enced members’ health screening behavior.
Despite these limitations, our findings suggest that
response to reminders differs according to patient char-
acteristics. In particular, targeted interventions may be
needed to encourage screening for members in the
youngest age ranges recommended for screening, which
differed by screening category. The younger members
who were sent reminder letters had low response rates;
the potential to improve their life expectancy and their
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quality-adjusted life years would be the greatest among
the age groups examined in this study. We also found that
members who obtained one recommended screening were
more likely to obtain others. This finding suggests that
sending a single reminder detailing all needed screenings
might be the most effective option. Further research is
needed to determine how health plans can best reach
members who do not respond to patient reminders.
Acknowledgments
This study was funded by the Hawaii Medical Service
Association. The Hawaii Medical Service Association is an
independent licensee of the Blue Cross and Blue Shield
Association.
Author Information
Corresponding Author: Jun Zhu, PhD, Hawaii Medical
Service Association, Care Management, PO Box 860,
Honolulu, HI 96808-0860. Telephone: 808-948-6825. 
E-mail: jun_zhu@hmsa.com.
Author Affiliations: James Davis, PhD, Deborah A.
Taira, ScD, Hawaii Medical Service Association and John
A. Burns School of Medicine, Honolulu, Hawaii; Marisa
Yamashita, Hawaii Medical Service Association, Honolulu,
Hawaii.
References
1. U.S. Preventive Services Task Force. Guide to clinical
preventive services, periodic updates. Rockville (MD):
Agency for Healthcare Research and Quality,2003.
2. Baker LC, Phillips KA, Haas JS, Liang SY, Sonneborn
D. The effect of area HMO market share on cancer
screening. Health Serv Res 2004;39(6 Pt 1):1751-72.
3. Liang SY, Phillips KA, Tye S, Haas JS, Sakowski J.
Does patient cost sharing matter? Its impact on rec-
ommended versus controversial cancer screening serv-
ices. Am J Manag Care 2004;10(2 Pt 1):99-107.
4. Phillips KA, Haas JS, Liang SY, Baker LC, Tye S,
Kerlikowske K, et al. Are gatekeeper requirements
associated with cancer screening utilization? Health
Serv Res 2004;39(1):153-78.
5. Hsia J, Kemper E, Kiefe C, Zapka J, Sofaer S,
Pettinger M, et al. The importance of health insurance
as a determinant of cancer screening: evidence from
the Women’s Health Initiative. Prev Med
2000;31(3):261-70.
6. Goldberg D, Schiff GD, McNutt R, Furumoto-Dawson
A, Hammerman M, Hoffman A. Mailings timed to
patients’ appointments: a controlled trial of fecal occult
blood test cards. Am J Prev Med 2004;26(5):431-5.
7. Margolis KL, Menart TC. A test of two interventions to
improve compliance with scheduled mammography
appointments. J Gen Intern Med 1996;11(9):539-41.
8. Hardcastle JD, Farrands PA, Balfour TW,
Chamberlain J, Amar SS, Sheldon MG. Controlled
trial of faecal occult blood testing in the detection of
colorectal cancer. Lancet 1983;2(8340):1-4.
9. Hogg WE, Bass M, Calonge N, Crouch H, Satenstein
G. Randomized controlled study of customized preven-
tive medicine reminder letters in a community prac-
tice. Can Fam Physician 1998;44:81-8.
10. Turner KM, Wilson BJ, Gilbert FJ. Improving breast
screening uptake: persuading initial non-attenders to
attend. J Med Screen 1994;1(3):199-202.
11. Schofield PE, Cockburn J, Hill DJ, Reading D.
Encouraging attendance at a screening mammogra-
phy programme: determinants of response to different
recruitment strategies. J Med Screen 1994;1(3):144-9.
12. Clark DO, Von Korff M, Saunders K, Baluch WM,
Simon GE. A chronic disease score with empirically
derived weights. Med Care 1995;33(8):783-95.
13. Stone EG, Morton SC, Hulscher ME, Maglione MA,
Roth EA, Grimshaw JM, et al. Interventions that
increase use of adult immunization and cancer screen-
ing services: a meta-analysis. Ann Intern Med
2002;136(9):641-51.
14. Wagner TH. The effectiveness of mailed patient
reminders on mammography screening: a meta-analy-
sis. Am J Prev Med 1998;14(1):64-70.
15. Gimotty PA, Burack RC, George JA. Delivery of pre-
ventive health services for breast cancer control: a lon-
gitudinal view of a randomized controlled trial.
Health Serv Res 2002;37(1):65-85.
6 Centers for Disease Control and Prevention • www.cdc.gov/pcd/issues/2006/apr/05_0063.htm
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only
and does not imply endorsement by any of the groups named above.Tables
Table 1. Number of Health Plan Members Sent Screening Reminders by Age and Sexa
Male NA NA >50 (60,616) >45 (36,709) 35-65 (31,298)
Female 41-90 (42,245) 18-65 (71,697) >50 (68,398) >45 (46,514) 45-65 (22,391)
aNA indicates not applicable.
Table 2. Screening Response Rates to Reminders by Number of Reminders Sent and Type of Screening
1 23.9 29.6 21.5 30.8 25.3
2 19.1 20.0 15.8 26.4 20.4
>3 12.7 13.0 13.3 23.3 18.5
Table 3. Screening Rate Ratios by Health Plan Member Characteristics and Type of Screeninga
No. of reminders
1 1.00 1.00 1.00 1.00 1.00
2 0.61 (0.58-0.64) 0.64 (0.62-0.66) 0.71 (0.69-0.73) 0.95 (0.93-0.98) 0.75 (0.72-0.78)
>3 0.37 (0.35-0.40) 0.38 (0.37-0.40) 0.52 (0.50-0.54) 0.79 (0.76-0.83) 0.62 (0.60-0.65)
Sex
Male NA NA 1.00 1.00 1.00
Female NA NA 1.09 (1.07-1.12) 0.97 (0.94-0.99) 1.04 (1.00-1.07)
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Breast Cancer,  Cervical Cancer,  Colon Cancer,  Diabetes,  Cholesterol, 
Sex Age, y (No.) Age, y (No.) Age, y (No.) Age, y (No.) Age, y (No.)
Type of Screening
Breast Cancer Cervical Cancer Colon Cancer Diabetes Cholesterol
No. of Reminders Rate, % Rate, % Rate, % Rate, % Rate, %
Type of Screeningb
Breast Cancer Cervical Cancer Colon Cancer Diabetes Cholesterol
Member Characteristic Ratio (95% CI) Ratio (95% CI) Ratio (95% CI) Ratio (95% CI) Ratio (95% CI)
aAnalyses were adjusted for the island of residence in Hawaii and for the characteristics listed in Table 4.
bCI indicates confidence interval; NA, not applicable.
cAdjusted Clinical Group (ACG) morbidity levels were determined by Johns Hopkins University School of Hygiene and Public Health (2). The ACG morbidity
levels measure the level of overall illness experienced on a scale of 0 to 5, with 5 indicating the most ill.
(Continued on next page)VOLUME 3: NO. 2
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Age, y
<20 NA 1.00 NA NA NA
21-30 NA 1.96 (1.86-2.06) NA NA NA
31-40 NA 1.63 (1.55-1.71) NA NA 1.00
41-50 1.00 1.39 (1.33-1.46) 1.00 1.00 1.43 (1.37-1.49)
51-60 1.15 (1.08-1.22) 1.04 (0.99-1.10) 1.13 (1.08-1.17) 1.22 (1.19-1.25) 1.83 (1.75-1.92)
61-70 1.01 (0.95-1.08) 0.75 (0.70-0.80) 1.16 (1.11-1.20) 1.14 (1.10-1.18) 1.95 (1.82-2.08)
71-80 0.47 (0.42-0.52) NA 1.10 (1.04-1.15) 0.80 (0.76-0.84) NA
81-90 0.21 (0.18-0.24) NA 0.79 (0.74-0.83) 0.66 (0.61-0.72) NA
>91 NA NA 0.48 (0.42-0.55) 0.63 (0.51-0.79) NA
Morbidity levelc
0 1.00 1.00 1.00 1.00 1.00
1 1.40 (1.28-1.52) 1.36 (1.30-1.42) 1.41 (1.33-1.49) 1.16 (1.11-1.21) 1.26 (1.20-1.32)
2 1.57 (1.44-1.70) 1.53 (1.46-1.61) 1.63 (1.54-1.72) 1.39 (1.33- 1.45) 1.60 (1.52-1.69)
3 1.80 (1.65-1.97) 1.74 (1.65-1.84) 1.80 (1.70-1.91) 1.63 (1.55- 1.71) 2.06 (1.94- 2.19)
4 1.74 (1.57-1.92) 1.76 (1.64-1.88) 1.75 (1.64-1.86) 1.68 (1.58- 1.78) 1.98 (1.82- 2.16)
5 1.62 (1.45-1.82) 1.66 (1.52-1.81) 1.70 (1.59-1.81) 1.75 (1.62-1.88) 2.38 (2.13-2.66)
Type of coverage
Fee for service 1.00 1.00 1.00 1.00 1.00
Health maintenance organization 1.48 (1.43-1.54) 1.53 (1.49-1.57) 1.47 (1.44-1.51) 1.27 (1.24-1.30) 1.58 (1.53-1.63)
Medicare 1.21 (1.13-1.30) 1.21 (1.00-1.48) 1.54 (1.49-1.59) 1.63 (1.44-1.86) 1.86 (1.31-2.64)
aAnalyses were adjusted for the island of residence in Hawaii and for the characteristics listed in Table 4.
bCI indicates confidence interval; NA, not applicable.
cAdjusted Clinical Group (ACG) morbidity levels were determined by Johns Hopkins University School of Hygiene and Public Health (2). The ACG morbidity
levels measure the level of overall illness experienced on a scale of 0 to 5, with 5 indicating the most ill.
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Table 3. (continued) Screening Rate Ratios by Health Plan Member Characteristics and Type of Screeninga
Type of Screeningb
Breast Cancer Cervical Cancer Colon Cancer Diabetes Cholesterol
Member Characteristic Ratio (95% CI) Ratio (95% CI) Ratio (95% CI) Ratio (95% CI) Ratio (95% CI)Table 4. Screening Rate Ratios by Medical History and Type of Screeninga
Office visits in past year
0 1.00 1.00 1.00 1.00 1.00
1 1.08 (1.01-1.14) 1.03 (0.99-1.07) 1.07 (1.03-1.10) 1.25 (1.20-1.29) 1.01 (0.92-1.12)
2-5 1.04 (0.99-1.09) 1.02 (0.98-1.06) 1.09 (1.06-1.13) 1.41 (1.37-1.46) 0.97 (0.89-1.05)
6-10 1.01 (0.94-1.07) 0.99 (0.94-1.04) 1.16 (1.12-1.21) 1.64 (1.57-1.71) 1.05 (0.91-1.21)
11-25 1.08 (1.00-1.16) 1.05 (0.98-1.12) 1.19 (1.14-1.24) 1.84 (1.74-1.95) 1.22 (0.97-1.53)
>26 0.97 (0.83-1.13) 1.06 (0.91-1.23) 1.27 (1.16-1.39) 2.08 (1.78-2.42) 1.35 (0.78-2.34)
Emergency room visits in past year
0 1.00 1.00 1.00 1.00 1.00
>1 0.89 (0.83-0.95) 0.94 (0.90-0.98) 0.89 (0.86-0.93) 0.97 (0.92-1.02) 1.01 (0.84-1.20)
Hospitalizations in past year
0 1.00 1.00 1.00 1.00 1.00
>1 0.82 (0.75-0.90) 0.97 (0.91-1.04) 0.85 (0.81-0.90) 1.00 (0.93-1.07) 0.67 (0.49-0.90)
Provider specialty
Primary care 1.06 (1.01-1.11) 0.91 (0.88-0.95) 1.17 (1.14-1.20) 1.06 (1.03-1.09) 1.04 (1.00-1.09)
Endocrinology 1.07 (0.97-1.18) 0.96 (0.88-1.05) 1.17 (1.11-1.24) 1.04 (0.95-1.13) 1.22 (1.06-1.41)
Cardiology 1.01 (0.95-1.08) 0.88 (0.82-0.95) 1.02 (0.99-1.06) 1.02 (0.96-1.07) 1.13 (1.02-1.24)
Obstetrics/gynecology 1.99 (1.90-2.08) 1.84 (1.76-1.91) 1.58 (1.54-1.63) 0.99 (0.96-1.02) 0.98 (0.93-1.03)
Other 1.10 (1.05-1.15) 1.06 (1.02-1.09) 1.20 (1.17-1.22) 0.91 (0.88-0.94) 0.93 (0.89-0.97)
aAnalyses were adjusted for the island of residence in Hawaii and for the characteristics listed in Table 3.
bCI indicates confidence interval.
cData are from the year before health plan members received screening reminders.
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Type of Screeningb
Breast Cancer Cervical Cancer Colon Cancer Diabetes Cholesterol
Medical Historyc Ratio (95% CI) Ratio (95% CI) Ratio (95% CI) Ratio (95% CI) Ratio (95% CI)VOLUME 3: NO. 2
APRIL 2006
Table 5. Screening Rate Ratios by Multiple Reminders for Overdue Health Screenings Sent to Health Plan Members and by
Type of Screeninga
Breast cancer — 0.22 (0.20-0.23) 0.46 (0.44-0.48) 0.80 (0.76-0.83) 0.85 (0.79-0.91)
Cervical cancer 0.38 (0.37-0.40) — 0.54 (0.51-0.57) 1.09 (1.05-1.13) 0.97 (0.91-1.02)
Colon cancer 0.49 (0.47-0.51) 0.55 (0.52-0.58) — 0.88 (0.86-0.90) 1.06 (1.02-1.10)
Diabetes 0.88 (0.83-0.93) 0.76 (0.71-0.81) 0.59 (0.57-0.61) — 0.23 (0.22-0.25)
Cholesterol 0.97 (0.90-1.05) 0.95 (0.88-1.02) 0.58 (0.55-0.62) 0.19 (0.18-0.20) —
aMultiple reminders refer to reminders for recommended screenings in addition to the listed screening category (i.e., members receiving a reminder for cervi-
cal cancer screening when the analysis outcome is breast cancer screening). Rate ratios measure the screening rates for members who received more than
one reminder compared with those who did not. Analyses were adjusted for the island of residence in Hawaii and for the characteristics listed in Tables 3
and 4.
bCI indicates confidence interval.
Table 6. Screening Rate Ratios by Multiple Screenings Received and Type of Screeninga
Breast cancer — 10.3 (9.6-11.0) 3.65 (3.44-3.87) 1.32 (1.24-1.40) 1.34 (1.23-1.45)
Cervical cancer 7.89 (7.43-8.37) — 4.62 (4.31-4.96) 1.08 (1.02-1.14) 1.31 (1.22-1.40)
Colon cancer 2.91 (2.76-3.06) 3.66 (3.44-3.89) — 1.81 (1.75-1.87) 1.47 (1.40-1.54)
Diabetes 1.57 (1.45-1.69) 1.50 (1.39-1.62) 2.53 (2.41-2.65) — 23.9 (22.8-25.1)
Cholesterol 1.37 (1.25-1.51) 1.60 (1.46-1.74) 2.06 (1.92-2.21) 19.6 (18.7-20.4) —
aMultiple screenings refer to screenings other than the listed screening category (i.e., members having received screening for cervical cancer when the
analysis outcome is breast cancer screening). Rate ratios measure the screening rates for members who received more than one screening compared with
those who did not. Analyses were adjusted for the island of residence in Hawaii and for the characteristics listed in Tables 3 and 4.
bCI indicates confidence interval.
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Type of Screeningb
Breast Cancer Cervical Cancer Colon Cancer Diabetes Cholesterol
Reminders Ratio (95% CI) Ratio (95% CI) Ratio (95% CI) Ratio (95% CI) Ratio (95% CI)
Type of Screeningb
Breast Cancer Cervical Cancer Colon Cancer Diabetes Cholesterol
Screenings Ratio (95% CI) Ratio (95% CI) Ratio (95% CI) Ratio (95% CI) Ratio (95% CI)